Aurintricarboxylic Acid CAS: 4431-00-9
MF: C22H14O9
MW: 422.34
A cell-permeable apoptosis inhibitor.

Aurintricarboxylic Acid (CAS 4431-00-9)

  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 131ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Aurintricarboxylic Acid is rated 5.0 out of 5 by 1.
5
1
4
0
3
0
2
0
1
0
Alternative Namen: ATA; 5-[(3-carboxy-4-hydroxyphenyl)-(3-carboxy-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]-2-hydroxybenzoic acid
Anwendungen Aurintricarboxylic Acid is a cell-permeable apoptosis inhibitor
CAS Nummer: 4431-00-9
Reinheit: ≥85%
Molekulargewicht: 422.34
Summenformel: C22H14O9
Ausschließlich für Forschungszwecke. Nicht Geeignet für Verwendung in Diagnostik oder Therapie.
* Schauen Sie auf das Analysezertifikat (CoA), um die genauen Daten (inkl. Wassergehalt) Ihrer Produktionscharge (Lot) zu sehen.

Aurintricarboxylic Acid a cell-permeable polyanionic, polyaromatic compound employed as a powerful inhibitor of cellular processes, including apoptosis, that are dependent on the formation of protein-nucleic acid complexes. It binds to a FGF and reduces its angiogenic activity. Aurintricarboxylic Acid has been shown to inhibit apoptotic cell death in various cell types induced by a variety of factors. It has also been demonstrated to be a potent inhibitor of DNA topoisomerase II (IC50= 75 nM for the yeast enzyme as measured by relaxation assays) that inhibits angiogenesis. Aurintricarboxylic Acid inhibits von Willebrand factor binding to platelets and reduces glutamate-induced neuronal injury. Aurintricarboxylic Acid also stimulates the tyrosine phosphorylation of MAP kinases, Shc proteins, phosphatidylinositol 3-kinase, and phospholipase Cγ and inhibits both major calpain isoforms (IC50 = 22 µM and IC50 = 10 μM for μ-calpain and m-calpain, respectively).


Literaturhinweise

1. Sarma, M.H., et al. 1976. Biochim. Biophys. Acta. 418: 29-38. PMID: 1244850
2. González, R.G., et al. 1980. Biochemistry. 19: 4299-4303. PMID: 6158332
3. Posner, A., et al. 1995. Biochem. Mol. Biol. Int. 36: 291-299. PMID: 7663433
4. Benchokroun, Y., et al. 1995. Biochem. Pharmacol. 49: 305-313. PMID: 7857317
5. Okada, N., et al. 1995. J. Biol. Chem. 270: 16464-16469. PMID: 7608219
6. Okada, N., et al. 1997. Biochem. Biophys. Res. Commun. 230: 266-269. PMID: 9016763
7. Rui, H., et al. 1998. J. Biol. Chem. 273: 28-32. PMID: 9417042
8. Aronica, E.M., et al. 1998. Proc. Natl. Acad. Sci. U.S.A. 95: 7115-7120. PMID: 9618548

Erscheinung :
Powder
Aggregatzustand :
Solid
Löslichkeit :
Soluble in water (7 mg/mL), 1 M NH4OH (10 mg/mL), ethanol (60 mg/mL), 0.1 M NaOH (35 mg/mL), and aqueous alkali.
LAGERUNG: :
Store at room temperature
Schmelztemperatur :
300° C (lit.)
Sidepunkt :
759.64° C at 760 mmHg (Predicted)
Dichte :
1.6 g/cm3 (Predicted)
Brechungsindex :
n20D 1.75 (Predicted)
IC50 :
DNA topoisomerase II: IC50 = 75 nM; -calpain: IC50 = 22 µM; m-calpain: IC50 = 10 µM; MT4 : IC50 = 0.5 µg/mL (human); CEM : IC50 = 1.2 µg/mL (human); Human immunodeficiency virus 1: EC5050 = 76 nM
pK Werte :
pKa: 2.20 (Predicted)
Ausschließlich für Forschungszwecke. Nicht Geeignet für Verwendung in Diagnostik oder Therapie.
Deutsche WGK :
3
RTECS :
GU4790000
PubChem CID :
2259
MDL-Nummer :
MFCD00011663
EC-Nummer :
224-628-1
Beilstein-Registernummer :
2228904
SMILES :
C1=CC(=C(C=C1C(=C2C=CC(=O)C(=C2)C(=O)O)C3=CC(=C(C=C3)O)C(=O)O)C(=O)O)O

SDS (MSDS) herunterladen

Analysenzertifikat

Um PDF-Dokumente zu Drucken oder zu Bearbeiten
benötigen Sie Adobe Acrobat Reader

Aurintricarboxylic Acid (CAS 4431-00-9)  Publikationen

Lesen Sie wie andere Anwender Aurintricarboxylic Acid (CAS 4431-00-9) eingesetzt haben. Klicken Sie auf den jeweiligen Eintrag um den entsprechenden PubMed-Abstract abzurufen .

Produktreferenz 1 bis 10 von 11 insgesamt

PMID: # 28223427  Noguchi, F. et al. 2017. Mol. Cancer Ther. 16: 936-947.

PMID: # 20006589  Dejeans, N. et al. 2010. Biochem. Pharmacol. 79: 1221-30.

PMID: # 19340923  Kodama, Y. et al. 2009. Biochimie. -.

PMID: # 16806822  El Kebir, D. et al. 2006. Cell. Signal. 18: 2302-2313.

PMID: # 16928960  Robert, F. et al. 2006. Mol. Biol. Cell. 17: 4632-4644.

PMID: # 16822833  Schaletzky, J. et al. 2006. Mol. Biol. Cell. 17: 3860-3869.

PMID: # 16246361  Takaya, N. et al. 2005. J. Mol. Cell. Cardiol. 39: 856-864.

PMID: # 15671063  Ma, R. Y. M. et al. 2005. J Cell Sci. 118: 795-806.

PMID: # 11099777  Cavaliere, F. et al. 2001. Neurochem. Int. 38: 199-207.

PMID: # 9795126  Solovyan, V. et al. 1998. Brain Res. Mol. Brain Res. 62: 43-55.

Produktreferenz 1 bis 10 von 11 insgesamt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 120ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 11ms
  • REVIEWS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;

Santa Cruz Biotechnology, Inc. ist weltweit führend in der Entwicklung von Produkten für den biomedizinischen Forschungsmarkt. Rufen Sie uns an, gebührenfrei unter 00800 4573 8000. .
Copyright © 2007-2020, Santa Cruz Biotechnology, Inc. Alle Rechte vorbehalten. "Santa Cruz Biotechnology", das Santa Cruz Biotechnology, Inc. Logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", das San Juan Ranch Logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz" und "EZ Touch" sind eingetragene Warenzeichen der Santa Cruz Biotechnology, Inc. Alle genannte Warenzeichen sind Eigentum der jeweiligen Inhaber. Alle Rechte vorbehalten.